An African Patient With Ziprasidone Intolerance

View This PDF

NB: This article is only available as a PDF.

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: The issue of ethnopsychopharmacology has been receiving increased attention lately. One study showed significant differences in treatment response in schizophrenia between various populations,1 but data on the subject are sparse, particularly for newer antipsychotic drugs. We report on a patient of African descent who developed intolerable side effects in response to ziprasidone, a recently approved atypical antipsychotic medication.​

J Clin Psychiatry 2005;66(6):800